Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2026-04-15 @ 3:18 AM
Study NCT ID:
NCT04359667
Status:
UNKNOWN
Last Update Posted:
2020-11-12
First Post:
2020-04-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With Tocilizumab
Sponsor:
University Hospital for Infectious Diseases, Croatia
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
UHID-04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None